Norges Bank
OPTR

Norges Bank’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Norges Bank’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-95,877
Closed -$1.21M – 2126
2013
Q3 		$1.21M Hold
95,877
– – ﹤0.01% 2063
2013
Q2 		$1.39M Buy
+95,877
New +$1.4M ﹤0.01% 2079

Norges Bank's OPTR Position: Q4 2013 in Review

Norges Bank sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 95,877 shares — an estimated $1.21M sold.

Norges Bank first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.39M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Norges Bank reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Norges Bank sold 95,877 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.21M.
  • Norges Bank first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Norges Bank's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.39M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Norges Bank's 13F filing for Q4 2013, filed 7 Feb 2014.